The biology of colorectal cancer

Seminars in Oncology

Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 2-9

  Dicato, M ^a   Berchem, G ^a   Duhem, C ^a   Ries, F ^a  

^a Centre Hospitalier   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

APC; PROTEIN P53;

APOPTOSIS; CELL ACTIVATION; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; COLORECTAL CARCINOMA; CONFERENCE PAPER; FAMILIAL CANCER; GENE SEQUENCE; HUMAN; METHYLATION; MOLECULAR CLONING; ONCOGENE K RAS; PRIORITY JOURNAL;

CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMAN; INTESTINAL MUCOSA; METHYLATION; MUTATION; ONCOGENES;

EID: 0033791658     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Vogelstein B: A genetic model for colorectal tumorigenesis
2. Dietary fiber and the risk of colorectal cancer and adenoma in women
3. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
4. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
5. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
6. The role of cyclooxygenases in inflammation, cancer, and development
7. The evolution of cancer of the colon and rectum
8. Allelotype of colorectal carcinomas
9. Identification of a chromosome 18q gene that is altered in colorectal cancer
10. Identification of FAP locus genes from chromosome 5q21
11. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
12. Ki-ras oncogene and p53 tumor suppressor gene mutations in colorectal carcinomas from the european Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model
13. Mechanisms for the involvement of DNA methylation in colon carcinogenesis
14. Reduced genomic 5-methylcytosine content in human colonic neoplasia
15. Hypermethylation of the hMLH 1 promoter in colon cancer with microsatellite instability
16. Prevalence of ras gene mutations in colorectal cancer
17. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
18. Ras genes
19. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene
20. Induction of apoptosis and G2/M cell cycle arrest by DCC
21. Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer
22. Expression of the c-erbB-2 gene product (P-185) at different stages of neoplastic progression in the colon
23. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma lines
24. Colorectal cancer
25. Localization of the gene for familial adenomatous polyposis on chromosome 5
26. Chromosome 5 allele loss in human colorectal carcinomas
27. Novel germline APC mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes
28. Correlation between the location of germline mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients
29. Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5
30. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC
31. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
32. Heredity with reference to carcinoma
33. Cancer family G revisited: 1895-1970
34. Hereditary proximal colonic cancer
35. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource
36. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer
37. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
38. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
39. Genetic epidemiology of colon cancer
40. The International Collaborative Group on hereditary nonpolyposis colorectal cancer
41. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of micro-satellite instability in colorectal cancer
42. Genetic mapping of a locus predisposing to human colorectal cancer
43. Mismatch repair: Mechanisms and relationship to cancer susceptibility
44. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumours and mismatch repair-defective human tumor cell lines
45. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer